Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (211-220 of 339) with videos related to

Pageof 34
Sort By:
JAMA Cardiology|April 10, 2024
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, et al.
Blood|November 15, 2021
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosisAdi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, et al.
Cell|April 9, 2016
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AMLRishi V Puram, Monika S Kowalczyk, Carl G de Boer, et al.
Cell Stem Cell|May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic TargetRebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Iscience|April 25, 2023
The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope proteinCharles Zou, Hojong Yoon, Paul M C Park, et al.
Nature Medicine|August 30, 2011
Stem cell gene expression programs influence clinical outcome in human leukemiaKolja Eppert, Katsuto Takenaka, Eric R Lechman, et al.
American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.
Blood Advances|March 10, 2020
Identification of germline variants in adults with hemophagocytic lymphohistiocytosisPeter G Miller, Abhishek Niroula, John J Ceremsak, et al.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
The New England Journal of Medicine|June 22, 2017
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseSiddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, et al.
Pageof 34

Showing results (211-220 of 339) with videos related to

Sort By:
Pageof 34
JAMA Cardiology|April 10, 2024
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, et al.
Blood|November 15, 2021
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosisAdi Zoref-Lorenz, Jun Murakami, Liron Hofstetter, et al.
Cell|April 9, 2016
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AMLRishi V Puram, Monika S Kowalczyk, Carl G de Boer, et al.
Cell Stem Cell|May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic TargetRebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Iscience|April 25, 2023
The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope proteinCharles Zou, Hojong Yoon, Paul M C Park, et al.
Nature Medicine|August 30, 2011
Stem cell gene expression programs influence clinical outcome in human leukemiaKolja Eppert, Katsuto Takenaka, Eric R Lechman, et al.
American Journal of Hematology|November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemiaDaniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.
Blood Advances|March 10, 2020
Identification of germline variants in adults with hemophagocytic lymphohistiocytosisPeter G Miller, Abhishek Niroula, John J Ceremsak, et al.
Science Advances|November 29, 2023
Enhanced <i>TP53</i> reactivation disrupts <i>MYC</i> transcriptional program and overcomes venetoclax resistance in acute myeloid leukemiasYuki Nishida, Jo Ishizawa, Edward Ayoub, et al.
The New England Journal of Medicine|June 22, 2017
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseSiddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, et al.
Pageof 34